Journal of Cutaneous Immunology and Allergy (Feb 2021)

Switching to ixekizumab improves adalimumab‐induced interstitial lung disease in patients with psoriatic arthritis: A case report

Hideki Hayashi,
Minori Kusakabe,
Makoto Nagai,
Yasutomo Imai,
Kiyofumi Yamanishi

Affiliations

Hideki Hayashi: Department of Dermatology Hyogo College of Medicine Nishinomiya Japan
Minori Kusakabe: Department of Dermatology Hyogo College of Medicine Nishinomiya Japan
Makoto Nagai: Department of Dermatology Hyogo College of Medicine Nishinomiya Japan
Yasutomo Imai: Department of Dermatology Hyogo College of Medicine Nishinomiya Japan
Kiyofumi Yamanishi: Department of Dermatology Hyogo College of Medicine Nishinomiya Japan

DOI: https://doi.org/10.1002/cia2.12146
Journal volume & issue: Vol. 4, no. 1
pp. 22 – 23

Abstract

No abstracts available.

Published in Journal of Cutaneous Immunology and Allergy

ISSN: 2574-4593 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Dermatology; Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: https://www.frontierspartnerships.org/journals/journal-of-cutaneous-immunology-and-allergy

About the journal